RFG - Bristol Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$919K Buy
7,151
+135
+2% +$15.8K 0.22% 86
2026
Q1
$844K Buy
7,016
+13
+0.2% +$1.5K 0.23% 80
2025
Q4
$737K Sell
7,003
-122
-2% -$11.5K 0.21% 82
2025
Q3
$598K Sell
7,125
-65
-0.9% -$5.35K 0.17% 99
2025
Q2
$569K Sell
7,190
-2,141
-23% -$170K 0.18% 102
2025
Q1
$838K Sell
9,331
-1,184
-11% -$111K 0.28% 73
2024
Q4
$1.05M Buy
+10,515
New +$1.08M 0.34% 66

Other funds holding MRK

RFG - Bristol Wealth Advisors's MRK Position: Q2 2026 in Review

RFG - Bristol Wealth Advisors increased its Merck (MRK) stake by 1.9% in Q2 2026, buying an estimated $15.8K and bringing the position to 7,151 shares worth $919K. The position accounts for 0.22% of the portfolio, ranked #86.

RFG - Bristol Wealth Advisors first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.05M in Q4 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • RFG - Bristol Wealth Advisors held 7,151 shares of Merck worth $919K as of Q2 2026.
  • RFG - Bristol Wealth Advisors bought 135 Merck shares in Q2 2026, an estimated $15.8K.
  • Merck made up 0.22% of RFG - Bristol Wealth Advisors's portfolio in Q2 2026, its #86 holding.
  • RFG - Bristol Wealth Advisors first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • RFG - Bristol Wealth Advisors's Merck position peaked at $1.05M in Q4 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on RFG - Bristol Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.